Safety of beta‐nicotinamide mononucleotide (β‐NMN) pursuant the regulation (EU) 2015/2283 and the bioavailability of nicotinamide from this source in the context of Directive 2002/46/EC
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on beta‐nicotinamide mononucleotide (β‐NMN) as a...
Sign up to read the full analysisDocument type: News/Update. Agency: International - EFSA. Published: 2026-05-12.
Why this matters to food and beverage teams
This news update is worth screening if your team tracks international - efsa activity that could affect ingredients, labeling, plant operations, imports, or compliance timing.
The practical question is whether this changes food safety and label-control exposure. If it does, pull the source document and decide whether the item needs action now, monitoring, or no response.
Track this document and its deadlines
Get the full analysis, comment period alerts, and compliance calendar -- free for F&B professionals.
Sign Up Free